1. Home
  2. BOLD vs FFIE Comparison

BOLD vs FFIE Comparison

Compare BOLD & FFIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • FFIE
  • Stock Information
  • Founded
  • BOLD 2018
  • FFIE 2014
  • Country
  • BOLD United States
  • FFIE United States
  • Employees
  • BOLD N/A
  • FFIE N/A
  • Industry
  • BOLD
  • FFIE Auto Manufacturing
  • Sector
  • BOLD
  • FFIE Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • FFIE Nasdaq
  • Market Cap
  • BOLD 60.4M
  • FFIE 68.5M
  • IPO Year
  • BOLD 2024
  • FFIE N/A
  • Fundamental
  • Price
  • BOLD $2.35
  • FFIE $1.51
  • Analyst Decision
  • BOLD Strong Buy
  • FFIE
  • Analyst Count
  • BOLD 3
  • FFIE 0
  • Target Price
  • BOLD $23.00
  • FFIE N/A
  • AVG Volume (30 Days)
  • BOLD 84.8K
  • FFIE 5.8M
  • Earning Date
  • BOLD 11-07-2024
  • FFIE 11-06-2024
  • Dividend Yield
  • BOLD N/A
  • FFIE N/A
  • EPS Growth
  • BOLD N/A
  • FFIE N/A
  • EPS
  • BOLD N/A
  • FFIE N/A
  • Revenue
  • BOLD N/A
  • FFIE $537,000.00
  • Revenue This Year
  • BOLD N/A
  • FFIE $10,958.67
  • Revenue Next Year
  • BOLD N/A
  • FFIE $617.65
  • P/E Ratio
  • BOLD N/A
  • FFIE N/A
  • Revenue Growth
  • BOLD N/A
  • FFIE N/A
  • 52 Week Low
  • BOLD $2.33
  • FFIE $1.20
  • 52 Week High
  • BOLD $15.24
  • FFIE $156.00
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • FFIE 36.00
  • Support Level
  • BOLD N/A
  • FFIE $1.20
  • Resistance Level
  • BOLD N/A
  • FFIE $1.59
  • Average True Range (ATR)
  • BOLD 0.00
  • FFIE 0.17
  • MACD
  • BOLD 0.00
  • FFIE 0.06
  • Stochastic Oscillator
  • BOLD 0.00
  • FFIE 34.83

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About FFIE Faraday Future Intelligent Electric Inc.

Faraday Future Intelligent Electric Inc is a global shared intelligent mobility ecosystem. It is poised to break the boundaries between the Internet, IT, creative, and auto industries with product and service offerings that integrate new energy, AI, Internet, and sharing models.

Share on Social Networks: